Skip to content

LENSAR, Inc. LNSR Investment Proceeds

Investment Proceeds at other companies

Staar Surgical logo
Staar SurgicalSTAA
$1.65M+356%
Schering-Plough logo
Schering-PloughSGP
$1.5M-86.6%
Medtronic logo
MedtronicMDT
$2.12B-5.2%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s investment proceeds?
LENSAR, Inc. (LNSR) reported investment proceeds of $4M in Q1 2026.
How has LENSAR, Inc.'s investment proceeds changed year-over-year?
LENSAR, Inc.'s investment proceeds increased by 14.3% year-over-year, from $3.5M to $4M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.